Solution for injection - (0.02%) 0.4 mg/2 ml

Lanatozid C is a cardiac glycoside with positive inotropic effect. Its effects are similar with digoxin. It increases the myocardial contraction strength and decreases myocardial conductivity, especially the conductivity through the AV node.

Lanatozid C exerts positive inotropic effect and negative chronotropic effect.

Approximately 20% of the used dose is inactivated within 24 hours. Its effects disappear after 3 – 6 days. Digoxin is the metabolite of lanatoside C and it is eliminated through urine.

Lanatozid C is indicated in:

• the treatment of mild to moderately severe heart failure
• the treatment of paroxysmal supraventricular tachycardia.